Survodutide is a dual agonist peptide of the GLP-1 and glucagon receptors, known in the literature as BI 456906. It is studied within the metabolic field. NeoPeptidos offers it with ≥99% HPLC purity, for research use.
Technical profile
| Product | Survodutide |
|---|---|
| CAS | 2805997-46-8 |
| Molecular formula | C₁₉₂H₂₈₉N₄₇O₆₁ |
| Molecular weight | 4231.7 Da |
| Sequence | Dual GCG/GLP-1 agonist (lipidated peptide) |
| Purity | 99% HPLC |
| Presentation | Lyophilized vial; bacteriostatic water included |
| Use | For scientific research use only |
What is Survodutide?
Survodutide combines activation of the GLP-1 receptor (related to glucose and appetite) and the glucagon receptor (related to energy expenditure) in a single molecule. Because of that mechanism it is classified as a dual GLP-1/glucagon agonist.
Research context
Survodutide is the subject of metabolic research in ongoing preclinical and clinical studies on the regulation of glucose and body weight, and it has also been studied in the context of liver health.
The NeoPeptidos product is research-grade material, not a clinical medicine; it includes no indications or administration schedules and is intended exclusively for researchers.
Handling and reconstitution
See the reconstitution guide and the storage guide.
Quality and traceability
≥99% purity by HPLC and batch COA. See quality control.
🔬 Updated on September 27, 2026 · Reviewed by the NeoPeptidos team · Content for research purposes (RUO).